Second National Forum on Advanced Pharmaceutical and Biotech IP Licensing

Venue: Boston, MA, United States

Location: Boston,, United States

Event Date/Time: Jun 22, 2005 End Date/Time: Jun 23, 2005
Report as Spam


IP rights are crucial for pharmaceutical and biotech companies. In fact, company share value continues to be dependent upon the drugs, biologics or therapeutics that companies have a patent on and which can be brought to market. The pharmaceutical industry needs a constant pipeline of new products to ensure a future stream of revenue. Biotech also faces a challenge – securing he capital to develop its products. Partnering and licensing agreements bridge the gap and help to increase companies’ shareholder value.

Strategic alliances between pharma, biotech and research institutes are not a passing trend – they are here to stay. Whether or not partnering and licensing agreements are successful is largely dependant on both the legal and strategic advice given. In order to truly maximize shareholder value and to avoid future litigation, partnering and licensing agreements must reflect foresight, achieve longevity and take account of the different players involved. By having a thorough knowledge of IP law and the latest deal making developments, in-house counsel will serve their company's best interests. It is essential to also maintain an ongoing relationship with external counsel and to keep abreast of issues such as best practice valuation methodologies and what is happening further afield.

This forum will provide an opportunity for counsel, Intellectual Property and Business Development Officers to share best practices and master the challenges they face because of licensing activities. Up-to-the-minute case studies and presentations will show you how companies are negotiating the best deal and creating profitable long-term partnerships.


Additional Information

Conference @ $1977.80